Spineway (ALSPW) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.005x

Based on the latest financial reports, Spineway (ALSPW) has a cash flow conversion efficiency ratio of -0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-114.00K ≈ $-133.28K USD) by net assets (€23.06 Million ≈ $26.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Spineway stock valuation for the company's overall valuation and market capitalisation.

Spineway - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Spineway's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Spineway Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spineway ranked by their cash flow conversion efficiency. Explore cash flow quality index of Spineway to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
REGENCY SILVER CORP. F:ZJ9	N/A
JPMorgan Asia Growth & Income plc LSE:JAGI	0.008x
Future Consumer Limited NSE:FCONSUMER	-0.022x
PURE ENERGY MINLS F:AHG	0.008x
H3 Energy Limited AU:H3E	0.355x
Helios Energy Ltd AU:HE8	-0.020x
MRG Metals Ltd AU:MRQ	-0.043x
Mask Investments Limited NSE:MASKINVEST	-0.002x

Annual Cash Flow Conversion Efficiency for Spineway (2011–2025)

The table below shows the annual cash flow conversion efficiency of Spineway from 2011 to 2025. View latest Spineway stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€23.06 Million ≈ $26.96 Million	€424.00K ≈ $495.70K	0.018x	+113.61%
2024-12-31	€24.24 Million ≈ $28.34 Million	€-3.27 Million ≈ $-3.83 Million	-0.135x	+55.85%
2023-12-31	€19.05 Million ≈ $22.28 Million	€-5.83 Million ≈ $-6.81 Million	-0.306x	-315.53%
2022-12-31	€22.01 Million ≈ $25.73 Million	€-1.62 Million ≈ $-1.89 Million	-0.074x	+14.38%
2021-12-31	€20.88 Million ≈ $24.41 Million	€-1.79 Million ≈ $-2.10 Million	-0.086x	-111.09%
2020-12-31	€10.02 Million ≈ $11.71 Million	€-408.00K ≈ $-476.99K	-0.041x	+77.22%
2019-12-31	€6.49 Million ≈ $7.59 Million	€-1.16 Million ≈ $-1.36 Million	-0.179x	+95.04%
2018-12-31	€945.00K ≈ $1.10 Million	€-3.41 Million ≈ $-3.99 Million	-3.608x	-593.91%
2017-12-31	€1.77 Million ≈ $2.07 Million	€-922.00K ≈ $-1.08 Million	-0.520x	-241.43%
2016-12-31	€1.30 Million ≈ $1.52 Million	€-198.00K ≈ $-231.48K	-0.152x	-364.80%
2015-12-31	€3.02 Million ≈ $3.53 Million	€-99.00K ≈ $-115.74K	-0.033x	+91.21%
2014-12-31	€4.62 Million ≈ $5.41 Million	€-1.72 Million ≈ $-2.01 Million	-0.373x	-68.98%
2013-12-31	€5.12 Million ≈ $5.99 Million	€-1.13 Million ≈ $-1.32 Million	-0.221x	-167.96%
2012-12-31	€1.16 Million ≈ $1.36 Million	€378.00K ≈ $441.92K	0.324x	+172.35%
2011-12-31	€844.99K ≈ $987.88K	€-379.00K ≈ $-443.09K	-0.449x	--

About Spineway

PA:ALSPW France Medical Instruments & Supplies

Market Cap

$4.95 Million

€4.23 Million EUR

Market Cap Rank

#28777 Global

#515 in France

Share Price

€0.12

Change (1 day)

-0.83%

52-Week Range

€0.12 - €0.23

All Time High

€1000000.00